(Q39760677)

14 September 2017

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis (English)

1 reference

14 September 2017

0 references

0 references

0 references

1 reference

K Y Dadzie

1

1 reference

14 September 2017

A C Bird

2

1 reference

14 September 2017

K Awadzi

3

1 reference

14 September 2017

H Schulz-Key

4

1 reference

14 September 2017

H M Gilles

5

1 reference

14 September 2017

M A Aziz

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 1987

1 reference

14 September 2017

8

1 reference

British Journal of Ophthalmology

inferred from page(s)

published in

1 reference

14 September 2017

71

1 reference

14 September 2017

2

1 reference

14 September 2017

78-85

1 reference

Lesions of eye fundus in onchocerciasis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Ocular lesions of onchocerciasis in Africa

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Onchocercosis: criteria of evaluation of results in a rural therapeutic campaign

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

An onchocerciasic papillitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

The risk of optic atrophy following suramin treatment of ocular onchocerciasis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Efficacy and tolerance of ivermectin in human onchocerciasis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Selective preventive treatment of onchocerciasis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

The therapeutic difficulties of ocular onchocerciasis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Effects of suramin on ocular onchocerciasis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Effects of diethylcarbamazine on ocular onchocerciasis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

The populatin dynamics of Onchocerca volvulus microfilariae during treatment with suramin and diethylcarbamazine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Ivermectin: A Potent New Antiparasitic Agent

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041095

Comparison of the effect upon onchocerciasis of five drugs and selection of the one best able to prevent ocular complications

17 June 2018

1 reference

12 December 2020

[Treatment of human onchocerciasis with ivermectin]

1 reference

12 December 2020

Ocular Penetration of Hetrazan in Rabbits

1 reference

12 December 2020

Ivermectin in onchocerciasis

1 reference

12 December 2020

OCULAR COMPLICATIONS OF ONCHOCERCIASIS: THE PROBLEM OF THE VISUAL PROGNOSIS IN TREATED SUBJECTS

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.71.2.78

1 reference

14 September 2017

1 reference

14 September 2017

1 reference